Q1 2025 Holdings
Filed 2025-05-15 | 59 holdings | $112.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2025-05-16) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.7M | 165,496 | 5.1% |
| Guardant Health Inc(GH) | COM | 40131M109 | $5.4M | 127,182 | 4.8% |
| Geron Corp(GERN) | COM | 374163103 | $5.1M | 3,215,457 | 4.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.7M | 32,534 | 4.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.2M | 103,483 | 3.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.1M | 337,198 | 3.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $4.1M | 135,616 | 3.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $3.9M | 4,673 | 3.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.7M | 621,678 | 3.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $3.1M | 6,358 | 2.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $3.1M | 43,441 | 2.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $3.1M | 76,379 | 2.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.1M | 61,656 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.9M | 217,294 | 2.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.9M | 405,281 | 2.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.9M | 294,846 | 2.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $2.7M | 84,339 | 2.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.7M | 258,391 | 2.4% |
| Natera Inc(NTRA) | COM | 632307104 | $2.6M | 18,650 | 2.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.6M | 353,882 | 2.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.4M | 9,000 | 2.1% |
| Savara Inc(SVRA) | COM | 805111101 | $2.3M | 836,397 | 2.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $2.2M | 116,623 | 1.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.1M | 118,017 | 1.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.1M | 142,744 | 1.8% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $2.1M | 25,400 | 1.8% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $2.0M | 689,137 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.8M | 102,944 | 1.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $1.8M | 263,841 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADS | 07725L102 | $1.8M | 6,500 | 1.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $1.7M | 51,295 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.6M | 71,438 | 1.4% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $1.5M | 117,500 | 1.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.5M | 289,690 | 1.4% |
| Karyopharm Therapeutics IncA | NOTE 3.000%10/1 | 48576UAA4 | $1.5M | 2,000,000 | 1.4% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $1.5M | 2,000,000 | 1.4% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.5M | 2,232,453 | 1.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.4M | 195,295 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.2M | 1,097,999 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $1.0M | 163,738 | 0.9% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $982.4K | 133,113 | 0.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $959.2K | 39,900 | 0.9% |
| Alvotech(ALVO) | ORDINARY SHARES | L01800108 | $871.3K | 90,100 | 0.8% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $731.2K | 462,801 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $534.5K | 13,100 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $454.5K | 60,600 | 0.4% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $387.0K | 114,145 | 0.3% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $363.0K | 189,087 | 0.3% |
| Travere Therapeutics IncCall | CALL | 89422G907 | $231.0K | 110,000 | 0.2% |
| Aldeyra Therapeutics IncPut | PUT | 01438T956 | $190.0K | 100,000 | 0.2% |